VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CANF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CANFCan-Fite BioPharma Ltd.
$2.83$21M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCANFQuarterly Financials

Can-Fite BioPharma Ltd. (CANF) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Can-Fite BioPharma Ltd. (CANF) quarterly income statement — complete revenue, gross profit & net income history

CANF Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20
Sales/Revenue101K101K179K179K158K158K155K196K196K196K197K204K204K205K204K251K250K148K150K211K
Revenue Growth %-36.08%-36.08%15.48%-8.67%-19.39%-19.39%-21.32%-3.92%-3.92%-4.39%-3.43%-18.73%-18.4%38.51%36%18.96%22.55%-25.25%-21.88%-81.68%
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit101K101K179K179K158K158K155K196K196K196K197K204K204K205K204K251K250K148K150K211K
Gross Margin %100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-36.08%-36.08%15.48%-8.67%-19.39%-19.39%-21.32%-3.92%-3.92%-4.39%-3.43%-18.73%-18.4%38.51%36%18.96%22.55%-25.25%-21.88%-81.68%
Operating Expenses2.55M2.55M2.2M2.2M2.21M2.21M1.99M2.06M1.98M2.91M3.28M2.78M2.27M2.58M4.23M3.76M3.38M2.32M3.7M2.69M
OpEx % of Revenue2524.75%2524.75%1227.37%1227.37%1395.57%1395.57%1283.23%1051.53%1010.2%1483.67%1664.97%1361.27%1114.71%1256.1%2074.51%1498.41%1353.2%1566.89%2468.67%1274.88%
Selling, General & Admin1.03M1.03M761K761K762.5K762.5K722K762K624K847K826K741K822K754K1.13M822K876K1.02M807K689K
SG&A % of Revenue1022.77%1022.77%425.14%425.14%482.59%482.59%465.81%388.78%318.37%432.14%419.29%363.24%402.94%367.8%554.41%327.49%350.4%686.49%538%326.54%
Research & Development1.52M1.52M1.44M1.44M1.44M1.44M1.27M1.3M1.36M2.06M2.45M2.04M1.45M1.82M3.1M2.94M2.51M1.3M2.9M2M
R&D % of Revenue1501.98%1501.98%802.23%802.23%913.29%913.29%817.42%662.76%691.84%1051.53%1245.69%998.04%711.76%888.29%1520.1%1170.92%1002.8%880.41%1930.67%948.34%
Other Operating Expenses0000-500-50000000000000000
Operating Income-2.45M-2.45M-2.02M-2.02M-2.05M-2.05M-1.83M-1.86M-1.78M-2.71M-3.08M-2.57M-2.07M-2.37M-4.03M-3.51M-3.13M-2.17M-3.55M-2.48M
Operating Margin %-2424.75%-2424.75%-1127.37%-1127.37%-1295.57%-1295.57%-1183.23%-951.53%-910.2%-1383.67%-1564.97%-1261.27%-1014.71%-1156.1%-1974.51%-1398.41%-1253.2%-1466.89%-2368.67%-1174.88%
Operating Income Growth %-19.64%-19.64%-10.03%-8.2%-14.74%24.52%40.51%27.52%13.82%-14.43%23.46%26.7%33.93%-9.17%-13.37%-41.59%18.22%49.23%22.88%11.18%
EBITDA-2.44M-2.44M-2.02M-2.02M-2.05M-2.05M-1.83M-1.86M-1.78M-2.71M-3.08M-2.57M-2.07M-2.37M-4.02M-3.51M-3.13M-2.17M-3.55M-2.48M
EBITDA Margin %-2413.37%-2413.37%-1125.7%-1125.7%-1295.25%-1295.25%-1180.81%-949.74%-908.16%-1381.89%-1563.2%-1259.56%-1013.24%-1154.39%-1972.79%-1397.21%-1251.6%-1464.86%-2366.67%-1173.22%
EBITDA Growth %-19.11%-19.11%-10.09%-8.25%-14.97%24.44%40.57%27.55%13.88%-14.45%23.48%26.73%33.94%-9.16%-13.37%-41.67%18.26%49.26%22.88%11.19%
D&A (Non-Cash Add-back)11.5K11.5K3K3K5005003.75K3.5K4K3.5K3.5K3.5K3K3.5K3.5K3K4K3K3K3.5K
EBIT-2.45M-2.45M-2.02M-2.02M-2.05M-2.05M-1.83M-1.86M-1.78M-2.71M-3.08M-2.57M-2.07M-2.37M-4.03M-3.51M-3.13M-2.17M-3.49M-2.48M
Net Interest Income11K11K77K77K68.5K68.5K113K103K111K162K347K44K-121K-64K-315K110K-86K293K-118K-96K
Interest Income11K11K77K77K68.5K68.5K127K106K111K162K363K44K000110K0293K21K0
Interest Expense00000014K3K0016K0121K64K315K086K0139K96K
Other Income/Expense11K11K56.5K56.5K68.5K68.5K182K103K114K162K64K44K-121K-64K-90K110K-86K293K-80K-96K
Pretax Income-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.55M-3.02M-2.53M-2.19M-2.43M-4.12M-3.4M-3.22M-1.88M-3.63M-2.58M
Pretax Margin %-2413.86%-2413.86%-1095.53%-1095.53%-1251.9%-1251.9%-1065.81%-898.98%-852.04%-1301.02%-1532.49%-1239.71%-1074.02%-1187.32%-2018.63%-1354.58%-1287.6%-1268.92%-2422%-1220.38%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.39M-2.96M-2.44M-2.43M-2.56M-4.12M-3.4M-3.22M-1.88M-3.63M-2.58M
Net Margin %-2413.86%-2413.86%-1095.53%-1095.53%-1251.9%-1251.9%-1065.81%-898.98%-852.04%-1218.37%-1500%-1196.57%-1192.65%-1249.76%-2018.63%-1354.58%-1287.6%-1268.92%-2422%-1220.38%
Net Income Growth %-23.26%-23.26%-18.7%-11.29%-18.44%17.17%44.09%27.82%31.36%6.79%28.24%28.21%24.42%-36.42%-13.35%-32.04%17.31%56.75%-108.08%12.65%
Net Income (Continuing)-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.55M-3.02M-2.53M-2.19M-2.43M-4.12M-3.4M-3.22M-1.88M-3.63M-2.58M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.21-0.21-0.24-0.24-0.33-0.33-0.33-0.42-0.42-0.66-1.11-0.93-0.81-0.90-3.03-1.86-1.86-1.17-2.34-1.68
EPS Growth %36.36%36.36%27.27%42.86%21.43%50%70.27%54.84%48.15%26.67%63.37%50%56.45%23.08%-29.49%-10.71%50.79%84.46%78.86%82.61%
EPS (Basic)-0.21-0.21-0.24-0.24-0.33-0.33-0.33-0.42-0.42-0.66-1.11-0.93-0.81-0.90-3.03-1.86-1.86-1.17-2.34-1.68
Diluted Shares Outstanding11.37M11.37M8.44M8.44M6.07M6.07M4.95M4.08M4.08M3.93M2.72M2.72M2.72M2.72M2.22M1.83M1.72M1.61M1.55M1.53M
Basic Shares Outstanding11.38M11.38M8.44M8.44M6.07M6.07M4.95M4.08M4.09M3.93M2.72M2.72M2.72M2.72M1.36M1.83M1.72M1.61M1.55M1.53M
Dividend Payout Ratio--------------------